The dynamic mutational burden characteristic of cSCC, as well as actinic keratosis, is accompanied by the progressive expansion of a repertoire of these neoepitopes, which have the potential to activate protective anti-tumor cytotoxic CD8+ T cell-mediated immune mechanisms, as mentioned above [74,75]. The gene discussed is CD8A; the disease is neoplasm.